Loading company…
VemiCo Ltd. develops postbiotic products derived from probiotic bacteria to support gut health and immune resilience.
Founded in 2018 in Basingstoke, UK, VemiCo Ltd. sells bioactive compounds derived from probiotic bacteria that interact with the immune system and gut barrier, serving health-conscious consumers and healthcare providers in North America and Europe. Revenue comes from partnerships, B2B supply and direct consumer sales, including licensing of bioactive compounds. Co-founders are George Tzortzis and Jelena Vulevic. The company has completed 2 deals, most recently on December 24, 2021, when it raised seed funding from returning investor SOSV.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in